Search images on Google Product Monograph
Active Ingredients:
- deferoxamine mesylate, 500 MG/VIAL
DIN: 01981242
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAMUSCULAR, INTRAPERITONEAL, INTRAVENOUS, SUBCUTANEOUS
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- V03 - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO, Wiki)
- V03A - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO)
- V03AC - Iron chelating agents (ATC, WHO)
- V03AC01 - DEFEROXAMINE (WHO)
Reference brand drug: Desferal
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 2ML
Pharmaceutical standard: MFR
External Links for Desferal 500Mg:
Search on Google
- Desferal 500Mg side effects
- Desferal 500Mg dosage
- deferoxamine mesylate side effects
- deferoxamine mesylate dosage
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find desferal 500mg photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.